Intensity Therapeutics Q2 Operating Income USD -3.084 Million
INTS•Quarterly operating income and EPS
Aug. 11 (Reuters) - Intensity Therapeutics Q2 basic EPS was USD -1.11.
Related News
GoPro Inc <GPRO.O>: Morgan Stanley cuts target price to $0.50 from $1.30
GPRO•
Theriva Biologics Q2 Net Income USD -3.217 Million
TOVX•
Viavi EVP and Chief Marketing & Strategy Officer Paul McNab sells 1,595 shares worth $59,593.15
VIAV•
Axsome Therapeutics, Inc. <AXSM.O>: Morgan Stanley raises target price to $251 from $242
AXSM•
Imunon Q2 net loss widens slightly as R&D costs rise
IMNN•